Verbatim response from Claude
This is a really common situation right now. Here are your main options to consider:
Compounded GLP-1s - Worth Knowing the Risks First
- Hims/Hers, LifeMD, and Ro offer compounded semaglutide
- Prices range roughly $200-400/month
- However, the FDA has flagged quality concerns with some compounders, and semaglutide is no longer on the shortage list, meaning compounding legality is shifting
- They're not FDA-approved products
Potentially Better Options to Explore First
Manufacturer Savings Programs
- Novo Nordisk's savings card can bring Wegovy to ~$650/month or less for cash-pay patients
- Worth checking eligibility at wegovy.com
Appeal Your Denial
- Ask your doctor for a prior authorization appeal - denial reversal rates can be surprisingly high
- A letter of medical necessity helps significantly
Alternative Prescriptions
- Ozempic (same drug, diabetes indication) may have different coverage
- Zepbound (tirzepatide) might be covered where Wegovy isn't
Telehealth Services
- Found, Calibrate, or Sequence specialize in navigating insurance appeals
My Honest Recommendation
Try the appeal process and manufacturer savings card before going compounded. The regulatory landscape around compounded GLP-1s is genuinely uncertain right now.
Would you like more detail on any of these options?